Interview: Ray O'Neill, Managing Director, ESS Ltd
Mr. O’Neill, you have been managing director of this company for 17 years. How have you evolved the business over that period? ESS was founded in 1991, and I joined…
Address: Takeda Ireland Limited (Bray), Bray Business park, Kilruddery, Co. Wicklow, ,Ireland
Tel: +353 (0)1 2050600
Takeda Ireland Limited (TIL) is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, a global research-based pharmaceutical company, the No 1 pharmaceutical company in Japan, and one of the world’s top 100 companies.
Established in Ireland since 1997, Takeda employs over 400 people in the following areas: manufacturing of drug products (DP), active pharmaceutical ingredients (API), process development, packaging, supply chain, sales and marketing.
Takeda Ireland Ltd – Bray (DP)
TIL Bray, a wholly-owned subsidiary of Takeda Pharmaceutical Company has played a key role in Takeda’s worldwide operations since being established in 1997. To date employing over 400 people and serving as the main pharmaceutical production base for blockbuster products to the European and U.S markets.
Takeda Ireland Ltd – Grange Castle (API)
In 2002 the first Takeda API (Active Pharmaceutical Ingredient) plant outside Japan was constructed in Clondalkin, Dublin 22, representing a key strategic addition to the group’s global production network. The plant will be the launch vehicle for new strategic products for global markets developing and producing API’s from clinical trial stages through to launch and full commercialisation.
Takeda Products Ireland Ltd
Based in Citywest, Takeda Products Ireland Limited was established to market Takeda’s products throughout the Republic of Ireland. Takeda Products Ireland Limited is dedicated to improving Irish patients’ lives by bringing to the market, new and better medicines, developed by Takeda and key partners, to help address the nation’s most pressing healthcare needs. This includes debilitating conditions in key areas such as Cancer, Pulmonary disease, Cardiovascular disease, Type II Diabetes and Pain Management. Our current product portfolio includes Prostap, Mepact, Actos, Competact, Blopress, Blopress Plus, Edarbi, Midon, Instanyl, Matrfien, Xeforapid, Daxas, Protium, Somac Control, Preotact, Alvesco and Tachosil.
Prostap, Mepact, Actos, Competact, Blopress, Blopress Plus, Edarbi, Midon, Instanyl, Matrfien, Xeforapid, Daxas, Protium, Somac Control, Preotact, Alvesco and Tachosil.
Mr. O’Neill, you have been managing director of this company for 17 years. How have you evolved the business over that period? ESS was founded in 1991, and I joined…
Mr. O’Neill, you have been managing director of this company for 17 years. How have you evolved the business over that period? ESS was founded in 1991, and I joined…
Mr. Moore, can you please introduce our readers to yourself and to SteriPack? SteriPack was founded in Clara, Ireland, in 1994. When I joined the organization 18 years ago, we…
Can you please introduce our readers to Deloitte Ireland and the firm’s life science practice? Brendan Jennings (BJ): Deloitte’s presence in Ireland dates back over one hundred years. We currently…
Can you please introduce yourself and Arthur Cox’s life science practice to our readers? I am a partner within the technology and life sciences group at Arthur Cox, and head…
Mr. Cooke, you joined Alkermes after the company acquired the Elan Drug Technologies (EDT) unit in 2011—a unit you headed for four years. Can you please begin by introducing yourself…
Mr. Somers, can you please introduce us to the Helsinn Group and its unique in-licensing model? Helsinn is a Swiss-based, private company owned by the Braglia family. The Braglias have…
Mylan embarked upon its first major international expansion program in 2007, after the acquisition of Merck KGaA’s generic medicines business. How has the organization subsequently evolved in the UK/Ireland market…
Mr. Keogh, you founded Millmount Healthcare in 1999. What was the vision behind the company? Prior to founding Millmount, I spent ten years in pharmaceutical manufacturing and contract packaging in…
Can you please introduce us to Dalkia? Pat Gilroy: Dalkia is a multinational company that operates in over 40 countries throughout the world and turns over 8Bn EUR annually. We…
Mr. Garrahy, can you please begin by introducing yourself and this production facility to our readers? I joined Rottapharm in 1998, when the organization decided to establish its Dublin production…
Mr. Moran, can you please begin with a brief introduction to Pharmachemical Ireland, its mission, and how it works to achieve its goals? Pharmachemical Ireland (PCI) is an industry…
See our Cookie Privacy Policy Here
